Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Abroad (travel likely)RecruitingPHASE4
Conditions
Liver Fat · Liver Fibrosis · Glycemic Control · Body Weight Changes · Waist Circumference · Tolerance
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
North west general hospital, Peshawar, KPK, Pakistan
Contact: Study coordinator (Arshad Hussain, M.B.B.S)
Study leads
Umar Raja, MBBS
Principal Investigator
Shifa International Hospital